Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine

Published:2019-08-28 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Lomberk Gwen^ORCID,Dusetti Nelson^ORCID,Iovanna Juan,Urrutia Raul^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-11812-7.pdf

Reference89 articles.

1. Lucas, A. L. et al. Global trends in pancreatic cancer mortality from 1980 through 2013 and predictions for 2017. Clin. Gastroenterol. Hepatol. 14, 1452–1462.e1454 (2016).

2. McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613–628 (2017).

3. Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371–385.e318 (2018).

4. Aguirre, A. J. et al. Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine. Cancer Discov. 8, 1096 (2018).

5. Balachandran, V. P. et al. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature 551, 512–516 (2017).

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MICAL2 Is a Super Enhancer Associated Gene that Promotes Pancreatic Cancer Growth and Metastasis;2024-06-30

2. Multiplexed molecular imaging identifies pancreatic cancer candidates for epigenetic modulators;2024-06-28

3. Inhibition of DEF‐p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer;Advanced Science;2024-05-17

4. From Data to Cure: A Comprehensive Exploration of Multi-omics Data Analysis for Targeted Therapies;Molecular Biotechnology;2024-04-02

5. Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer;Cancer Letters;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3